Global Vaccine Disposable Syringes Market to Reach USD 6.14 Billion by 2032, Growing at a CAGR of 6.6%

According to a new report from Intel Market Research, Global vaccine disposable syringes market was valued at USD 3.95 billion in 2024. It is projected to grow from USD 4.21 billion in 2025 to USD 6.14 billion by 2032, exhibiting a CAGR of 6.6% during the forecast period.

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/2667/global-vaccine-disposable-syringes-forecast-2025-2032-207

The steady market growth is driven by large-scale immunization programs, the rising prevalence of infectious and vaccine-preventable diseases, and technological advancements in syringe design such as auto-disable and prefilled systems. The global COVID-19 vaccination campaigns have further accelerated demand, highlighting the critical role of safe and efficient syringe delivery systems.

Regional Analysis

North America: Advanced healthcare infrastructure, strict regulatory standards, and high adoption of safety-engineered and prefilled syringes drive market growth.
Europe: Presence of major manufacturers like Gerresheimer AG and B. Braun Melsungen AG, coupled with regulatory mandates, supports sustained demand.
Asia-Pacific: Emerging economies such as India, China, and Japan are witnessing rapid adoption due to expanding vaccination programs, government initiatives, and cost-effective local manufacturing.
Latin America & Middle East & Africa: Growth is driven by international vaccination programs, including WHO and UNICEF initiatives, improving healthcare access, and donor-funded immunization campaigns.

Competitor Analysis (in brief)

The global vaccine disposable syringes market is consolidated, dominated by multinational companies with vertically integrated production:

Becton, Dickinson and Company (BD) – Market leader with 28% share, known for BD Ultra-Fine™ needle technology.
Gerresheimer AG & Terumo Medical Corporation – Combined 35% share; major focus on prefilled syringes and advanced safety solutions.
Regional Players – Hindustan Syringes & Medical Devices (India), NIPRO Medical Corporation (Japan) expanding market share through cost-effective solutions.

Key strategies include acquisitions, facility expansions, strategic partnerships, and technological innovation to meet growing vaccine administration needs globally.

Global Vaccine Disposable Syringes: Market Segmentation Analysis

This report provides a deep insight into the global vaccine disposable syringes market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine Disposable Syringes. This report introduces in detail the market share, market performance, product situation, operation situation, etc., of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine Disposable Syringes market in any manner.

Market Segmentation (by Application)

Immunization/Vaccination Injections
Therapeutic Injections
Diagnostic / Blood Collection
Others

Market Segmentation (by Type)

Luer Lock Syringes
Luer Slip Syringes
Prefilled Syringes
Safety Syringes
Others

By Needle Type

Fixed Needle – Accounts for majority share in vaccine administration
Detachable Needle

By Distribution Channel

Direct Sales to Hospitals/Clinics
Medical Supply Stores & Pharmacies
Online Platforms

Key Company

Becton, Dickinson and Company (U.S.)
Gerresheimer AG (Germany)
Terumo Medical Corporation (Japan)
NIPRO Medical Corporation (Japan)
B. Braun Melsungen AG (Germany)
Baxter International Inc. (U.S.)
Smiths Group PLC (U.K.)
Retractable Technologies, Inc. (U.S.)
Hindustan Syringes & Medical Devices (India)
McKesson Medical-Surgical Inc. (U.S.)
Agilent Technologies (U.S.)
ICU Medical (U.S.)

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/2667/global-vaccine-disposable-syringes-forecast-2025-2032-207

FAQ

Q1: What is the current market size of the Vaccine Disposable Syringes market?
A: The global market was valued at USD 3.95 billion in 2024 and is projected to reach USD 6.14 billion by 2032, growing at a CAGR of 6.6%.

Q2: Which are the key companies operating in the Vaccine Disposable Syringes market?
A: Key players include Becton, Dickinson and Company, Gerresheimer AG, Terumo Medical Corporation, NIPRO Medical Corporation, B. Braun Melsungen AG, Hindustan Syringes & Medical Devices, among others.

Q3: What are the key growth drivers in the Vaccine Disposable Syringes market?
A: Growth is driven by global immunization programs, technological advancements in safety and prefilled syringes, rising vaccine-preventable diseases, and expanding healthcare infrastructure.

Q4: Which regions dominate the Vaccine Disposable Syringes market?
A: North America, Europe, and Asia-Pacific dominate due to advanced healthcare systems, regulatory support, and rapid adoption in emerging markets.

Q5: What are the emerging trends in the Vaccine Disposable Syringes market?
A: Key trends include auto-disable syringes, prefilled syringe adoption, safety-engineered syringes, and development of specialized syringes for cold-chain vaccines and mRNA formulations.

About Us

Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in information technology, digital media solutions, and communication infrastructure. Our research capabilities include: